Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BioNTech News

Julian Parker 2026 Jun 17, 16:02

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

forex
Julian Parker 2026 Jun 17, 16:01

SpaceX Stock Forecast 2027, 2031 and 2036: What the Lockup Schedule Means for SPCX Shares

stocks
Julian Parker 2026 Jun 16, 16:03

USD/CAD Forecast: Oil Weakness Keeps 1.4000 in Focus

forex
Julian Parker 2026 Jun 16, 16:01

Bitcoin and the Fed’s Guidance Shift: Short-Term Risk, Long-Term Narrative

crypto
Julian Parker 2026 Jun 16, 16:01

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

indices
Julian Parker 2026 Jun 15, 16:02

Silver Price Forecast: XAG/USD Holds Below $70 as Fed Decision Shapes Outlook

commodity
Julian Parker 2026 Jun 15, 16:01

EUR/USD Outlook: Dollar Firms Before Fed Decision as Euro Rally Loses Momentum

forex
Julian Parker 2026 Jun 14, 16:05

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

cfd trading stocks
Julian Parker 2026 Jun 14, 16:02

How to Trade the SpaceX (SPCX) IPO Surge From South Africa With CFDs — Without Owning a Single Share

stocks
Julian Parker 2026 Jun 10, 16:01

SpaceX IPO Puts S&P 500 Inclusion Question in Focus

stocks

Latest news

Show more
Julian Parker 2026 Jun 21, 16:01

US-Iran Talks Hit Sudden Setback as Trump Threatens Fresh Strikes, Stock Futures Slide

Oil
Julian Parker 2026 Jun 17, 16:05

Today's Stock Prices: U.S. Stocks Fall, SpaceX Slides, Allbirds Soars 39%

Stock
Julian Parker 2026 Jun 17, 16:04

Gold Price Today, June 18, 2026: Spot Gold Slides Toward $4,250 as Fed Signals Possible 2026 Rate Hike

gold price today
Julian Parker 2026 Jun 17, 16:04

Brent Oil Price Today: Brent Falls Below $79 as US-Iran Peace Deal Drains War Premium

Commodities
Julian Parker 2026 Jun 17, 16:02

Kevin Warsh’s First Fed Decision Turns Hawkish as Dot Plot Revives 2026 Rate Hike Bets

Forex
Julian Parker 2026 Jun 16, 16:05

Gold Price Today, June 17, 2026: Gold Holds Near One-Week High as Oil Slump Eases Fed Rate-Hike Fears

gold price today
Julian Parker 2026 Jun 16, 16:02

Brent Crude Falls Below $80 as Goldman Sachs and Morgan Stanley Cut Oil Forecasts

Commodities
Julian Parker 2026 Jun 16, 16:01

SpaceX Stock Rally Extends as Options Debut Fuels Post-IPO Surge

Stock

Info

Spread

0.9161

Spread (%)

1.0117 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

22984650752

Shares Outstanding

252884261

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-5.88

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic colorectal and non-small cell lung cancer. In addition, the company engages in the development of oncology drugs under Phase II clinical trial comprising BNT116 for advance non-small cell lung cancer, BNT326/YL202 for multiple solid tumors and advanced/metastatic breast cancer, Autogene cevumeran for advance colorectal cancer, and Gotistobart for platinum-resistant ovarian cancer, as well as Pumitamig for glioblastoma, hepatocellular carcinoma, malignant pleural mesothelioma, neuroendocrine neoplasms, and metastatic pancreatic ductal adenocarcinoma. Further, it develops BNT166 which is Phase II clinical trial for mpox virus; and infectious diseases drugs under Phase 1/2 clinical trial, which include BNT162 + BNT161 for SARS-CoV-2 and influenza, BNT164 for tuberculosis, BNT165 for malaria, and BNT166 for mpox. The company was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Jun 17, 16:03

How to Open a Swap-Free Account: Full Step-by-Step Guide

Julian Parker 2026 Jun 17, 16:01

Is Forex & CFD Trading Halal? The Ultimate Guide to Islamic Trading Account

Julian Parker 2026 Jun 16, 16:04

High-Leverage Forex Brokers: What Traders Need to Know Before Using High Leverage

Trustpilot